Home Infusion Therapy Market By Product And Application - Global Industry Analysis And Forecast To 2022
Published On : November 2017 Pages : 90 Category: Medical Devices Report Code : HC11322
Industry Outlook and Trend Analysis
The global Home Infusion Therapy market was worth USD 10.14 billion in the year 2017 and is expected to reach approximately USD 24.98 billion by 2022, while registering itself at a compound annual growth rate (CAGR) of 9.43% during the forecast period. Key drivers adding to market extension incorporate the rising aged populace, augmentation in disease burden, and existence of high neglected therapeutic needs in the low income regions. The advent of smart pumps has empowered access to homecare infusion therapies. Such gadgets are improving the general usability for patients. Moreover, rising need for reducing inpatient stay owing to the related hospital costs has prompted the improvement of infusion therapy in alternate healthcare settings, for example, homecare, consequently bringing about general market development. Additionally, the developing need to contain healthcare services costs has prompted a higher inclination for homecare treatments among patients, particularly the elderly who need prolonged care and treatment. Infusion pumps provide various advantages in contrast with manual conveyance of liquids inferable from their capacity to manage the coveted volume of liquids at prearranged and automated intervals. Besides, the wide scale accessibility of smart infusion pumps offered by the key players is required to support the market demand. With the developing aged populace, there will be an expansion in the occurrence of different medicinal conditions requiring prolonged care. The high inclination of this patient subset to recuperation at home is relied upon to altogether boost the market development.
Product Outlook and Trend Analysis
Infusion pumps represented the biggest market share of more than 49 percent in 2017. This is principally because of the way that these gadgets were utilized as a part of inpatient offices worldwide and are presently being incorporated broadly in outpatient settings also. These pumps guarantee more prominent level of exactness and precision in conveying drugs thus prompting decreased blunders in drug administration. Consequently, this has prompted expanded selection of these gadgets accordingly prompting general development of this vertical. Needleless connectors are anticipated to be the quickest developing fragment over the estimate time frame attributable to advancements in technology of these connectors, bringing about diminished danger of wounds and infection transmission. Previously, roughly 385,000 injuries for each year were accounted for because of the utilization of needle connectors representing a high danger of pathogen transmission. Consequently, sooner rather than later these needleless gadgets are anticipated to contribute, to a huge degree, toward income generation.
Application Outlook and Trend analysis
Some of the most common treatments that are rendered to patients in home settings for curing diseases that require long-term care are Anti-infectives, comprising antivirals, antifungals and antibiotics. Subsequently, it contributed towards the biggest profit generation in 2017. The chemotherapy pumps utilized at home are constant pressure pumps that don't require a battery and are minimally sized. Thus, the chemotherapy portion is expected to achieve a lucrative growth during the forecast period. Endocrinology fragment is likewise assessed to witness gainful development inferable from the accommodation of utilizing insulin pumps.
Regional Outlook and Trend Analysis
In 2017 North America ruled the market with a profit of around USD 5.0 billion because of the existence of a well-established government repayment schemes in this locale. A few government health plans progressed by the Centers for Medicare and Medicaid Services and Federal Employees Health Benefits Program give repayment to infusion therapy. Asia Pacific is relied upon to pick up the most noteworthy CAGR over the gauge time frame inferable from the rising patient awareness levels in this locale. This is fundamentally because of the advantages of homecare treatments when contrasted with that of in-hospital infusion methods.
Competitive Insights
The major participants in the market are Terumo Corporation, Fresenius Kabi AG, B. Braun Melsungen, CareFusion Corporation, Baxter International, Smiths Medical, ICU Medical, Caesarea Medical Electronics and JMS Co. Ltd. The organizations are concentrating on mergers and acquisitions to enlarge their market existence. For example, in December 2017, CareFusion purchased 40% stake in Caesarea to extend its infusion item portfolio. Moreover, land developments and item dispatches are a portion of the significant techniques embraced by the organizations. For example, in April 2017, Smiths Medical propelled their wireless infusion system, CADD Solis for effective pain management, in Australia, United Kingdom, New Zealand, and Ireland.
The Global Home Infusion Therapy Market is segmented as follows-
By Product
- IV Cannulas
- Needleless Connectors
- Intravenous Sets
- Infusion pumps
- Ambulatory infusion pumps
- Elastomeric pumps
- Insulin pumps
- Patient Controlled Analgesics (PCA)
- Syringe pumps
By Application
- Specialty Pharmaceuticals
- Anti-Infective
- Enteral Nutrition
- Chemotherapy
- Hydration Therapy
- Athletes
- Others
- Endocrinology
- Diabetes
- Others
- Parenteral Nutrition
- Others
By Region
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2022?
- What will be the industry market growth from 2017 to 2022?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
- Home Infusion Therapy Market, By Product, Estimates and Forecast, 2012-2022 ($Million)
- Infusion Pumps
- Ambulatory infusion pumps
- Insulin Pumps
- Syringe Pumps
- Elastomeric Pumps
- Patient Controlled Analgesics (PCA)
- Intravenous Sets
- IV Cannulas
- Needleless Connectors
- Home Infusion Therapy Market, By Application, Estimates and Forecast, 2012-2022 ($Million)
- Anti-Infective
- Endocrinology
- Diabetes
- Others
- Hydration Therapy
- Athletes
- Others
- Chemotherapy
- Enteral Nutrition
- Parenteral Nutrition
- Speciality Pharmaceuticals
- Other Applications
- Home Infusion Therapy Market, By Region, Estimates and Forecast, 2012-2022 ($Million)
- North America
- North America Home Infusion Therapy Market, By Country
- North America Home Infusion Therapy Market, By Product
- North America Home Infusion Therapy Market, By Application
- U.S. Home Infusion Therapy Market, By Product
- U.S. Home Infusion Therapy Market, By Application
- Canada Home Infusion Therapy Market, By Product
- Canada Home Infusion Therapy Market, By Application
- Mexico Home Infusion Therapy Market, By Product
- Mexico Home Infusion Therapy Market, By Application
-
- Europe
- Europe Home Infusion Therapy Market, By Country
- Europe Home Infusion Therapy Market, By Product
- Europe Home Infusion Therapy Market, By Application
- Germany Home Infusion Therapy Market, By Product
- Germany Home Infusion Therapy Market, By Application
- France Home Infusion Therapy Market, By Product
- France Home Infusion Therapy Market, By Application
- UK Home Infusion Therapy Market, By Product
- UK Home Infusion Therapy Market, By Application
- Italy Home Infusion Therapy Market, By Product
- Italy Home Infusion Therapy Market, By Application
- Spain Home Infusion Therapy Market, By Product
- Spain Home Infusion Therapy Market, By Application
- Rest of Europe Home Infusion Therapy Market, By Product
- Rest of Europe Home Infusion Therapy Market, By Application
-
- Asia-Pacific
- Asia-Pacific Home Infusion Therapy Market, By Country
- Asia-Pacific Home Infusion Therapy Market, By Product
- Asia-Pacific Home Infusion Therapy Market, By Application
- Japan Home Infusion Therapy Market, By Product
- Japan Home Infusion Therapy Market, By Application
- Australia Home Infusion Therapy Market, By Product
- Australia Home Infusion Therapy Market, By Application
- India Home Infusion Therapy Market, By Product
- India Home Infusion Therapy Market, By Application
- South Korea Home Infusion Therapy Market, By Product
- South Korea Home Infusion Therapy Market, By Application
- Rest of Asia-Pacific Home Infusion Therapy Market, By Product
- Rest of Asia-Pacific Home Infusion Therapy Market, By Application
-
- Rest of the World
- Rest of the World Home Infusion Therapy Market, By Country
- Rest of the World Home Infusion Therapy Market, By Product
- Rest of the World Home Infusion Therapy Market, By Application
- Brazil Home Infusion Therapy Market, By Product
- Brazil Home Infusion Therapy Market, By Application
- South Africa Home Infusion Therapy Market, By Product
- South Africa Home Infusion Therapy Market, By Application
- Saudi Arabia Home Infusion Therapy Market, By Product
- Saudi Arabia Home Infusion Therapy Market, By Application
- Turkey Home Infusion Therapy Market, By Product
- Turkey Home Infusion Therapy Market, By Application
- United Arab Emirates Home Infusion Therapy Market, By Product
- United Arab Emirates Home Infusion Therapy Market, By Application
- Others Home Infusion Therapy Market, By Product
- Others Home Infusion Therapy Market, By Application
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Increasing Prevalence of Chronic Disorders
3.2.1.2. Rapid Technological Advancements
3.2.1.3. Home Healthcare as Cost Effective Alternative
3.2.2. Restraints
3.2.2.1. Presence of Complicated Reimbursement Framework and Reimbursement Cuts
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Home Infusion Therapy Market, By Product
4.1. Introduction
4.2. Home Infusion Therapy Market Assessment and Forecast, By Product, 2012-2022
4.3. Infusion Pumps
4.3.1. Market Assessment and Forecast, By Type, 2012-2022 ($Million)
4.3.2. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.3.3. Ambulatory infusion pumps
4.3.3.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.3.4. Insulin pumps
4.3.4.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.3.5. Syringe pumps
4.3.5.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.3.6. Elastomeric pumps
4.3.6.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.3.7. Patient Controlled Analgesics (PCA)
4.3.7.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.4. Intravenous Sets
4.4.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.5. IV Cannulas
4.5.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
4.6. Needleless Connectors
4.6.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
5. Home Infusion Therapy Market, By Application
5.1. Introduction
5.2. The Home Infusion Therapy Market Assessment and Forecast, By Application, 2012-2022
5.3. Anti-Infective
5.3.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
5.4. Endocrinology
5.4.1. Market Assessment and Forecast, By Type, 2012-2022 ($Million)
5.4.2. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
5.4.3. Diabetes
5.4.3.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
5.4.4. Others
5.4.4.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
5.5. Hydration Therapy
5.5.1. Market Assessment and Forecast, By Type, 2012-2022 ($Million)
5.5.2. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
5.5.3. Athletes
5.5.3.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
5.5.4. Others
5.5.4.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
5.6. Chemotherapy
5.6.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
5.7. Enteral Nutrition
5.7.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
5.8. Parenteral Nutrition
5.8.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
5.9. Speciality Pharmaceuticals
5.9.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
5.10. Other Applications
5.10.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)
6. Home Infusion Therapy Market, By Region
6.1. Introduction
6.2. Home Infusion Therapy Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.3. Home Infusion Therapy Market Assessment and Forecast, By Application , 2012-2022 ($Million)
6.4. North America
6.4.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)
6.4.2. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.4.3. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.4.4. U.S.
6.4.4.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.4.4.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.4.5. Canada
6.4.5.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.4.5.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.4.6. Mexico
6.4.6.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.4.6.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.5. Europe
6.5.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)
6.5.2. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.5.3. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.5.4. Germany
6.5.4.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.5.4.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.5.5. France
6.5.5.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.5.5.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.5.6. UK
6.5.6.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.5.6.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.5.7. Italy
6.5.7.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.5.7.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.5.8. Spain
6.5.8.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.5.8.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.5.9. Rest of Europe
6.5.9.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.5.9.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.6. Asia-Pacific
6.6.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)
6.6.2. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.6.3. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.6.4. Japan
6.6.4.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.6.4.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.6.5. China
6.6.5.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.6.5.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.6.6. Australia
6.6.6.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.6.6.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.6.7. India
6.6.7.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.6.7.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.6.8. South Korea
6.6.8.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.6.8.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.6.9. Rest of Asia-Pacific
6.6.9.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.6.9.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.7. Rest of the World
6.7.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)
6.7.2. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.7.3. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.7.4. Brazil
6.7.4.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.7.4.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.7.5. Turkey
6.7.5.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.7.5.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.7.6. Saudi Arabia
6.7.6.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.7.6.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.7.7. South Africa
6.7.7.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.7.7.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.7.8. United Arab Emirates
6.7.8.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.7.8.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
6.7.9. Others
6.7.9.1. Market Assessment and Forecast, By Product, 2012-2022 ($Million)
6.7.9.2. Market Assessment and Forecast, By Application, 2012-2022 ($Million)
7. Company Profiles
7.1. B. Braun Melsungen AG
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Key financials
7.1.4. Strategic Developments
7.2. Baxter Inc.
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Key Financials
7.2.4. Strategic Developments
7.3. Caesarea Medical Electronics
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Key Financials
7.3.4. Strategic Developments
7.4. CareFusion Corporation
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Key Financials
7.4.4. Strategic Developments
7.5. Fresenius Kabi
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Key Financials
7.5.4. Strategic Developments
7.6. ICU Medical Inc.
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Strategic Developments
7.7. JMS Co. Ltd.
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Key Financials
7.7.4. Strategic Developments
7.8. Smiths Medical
7.8.1. Business Overview
7.8.2. Product Portfolio
7.8.3. Strategic Developments
7.9. Terumo Corporation
7.9.1. Business Overview
7.9.2. Product Portfolio
7.9.3. Key Financials
7.9.4. Strategic Developments
List of Tables
Table 1.Global Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 2.Infusion Pumps Market, By Type, 2012-2022 ($Million)
Table 3.Infusion Pumps Market, By Region, 2012-2022 ($Million)
Table 4.Ambulatory Infusion Pumps Market, By Region, 2012-2022 ($Million)
Table 5.Insulin Pumps Market, By Region, 2012-2022 ($Million)
Table 6.Syringe Pumps Market, By Region, 2012-2022 ($Million)
Table 7.Elastomeric Pumps Market, By Region, 2012-2022 ($Million)
Table 8.Patient Controlled Analgesics (PCA) Market, By Region, 2012-2022 ($Million)
Table 9.Intravenous Sets Market, By Region, 2012-2022 ($Million)
Table 10.IV Cannulas Market, By Region, 2012-2022 ($Million)
Table 11.Needleless Connectors Market, By Region, 2012-2022 ($Million)
Table 12.Global Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 13.Anti-Infective Market, By Region, 2012-2022 ($Million)
Table 14.Endocrinology Market, By Type, 2012-2022 ($Million)
Table 15.Endocrinology Market, By Region, 2012-2022 ($Million)
Table 16.Diabetes Market, By Region, 2012-2022 ($Million)
Table 17.Others Market, By Region, 2012-2022 ($Million)
Table 18.Hydration Therapy Market, By Type, 2012-2022 ($Million)
Table 19.Hydration Therapy Market, By Region, 2012-2022 ($Million)
Table 20.Athletes Market, By Region, 2012-2022 ($Million)
Table 21.Others Market, By Region, 2012-2022 ($Million)
Table 22.Chemotherapy Market, By Region, 2012-2022 ($Million)
Table 23.Enteral Nutrition Market, By Region, 2012-2022 ($Million)
Table 24.Parenteral Nutrition Market, By Region, 2012-2022 ($Million)
Table 25.Speciality Pharmaceuticals Market, By Region, 2012-2022 ($Million)
Table 26.Other Applications Market, By Region, 2012-2022 ($Million)
Table 27.North America Home Infusion Therapy Market, By Country, 2012-2022 ($Million)
Table 28.North America Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 29.North America Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 30.U.S. Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 31.U.S. Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 32.Canada Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 33.Canada Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 34.Mexico Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 35.Mexico Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 36.Europe Home Infusion Therapy Market, By Country, 2012-2022 ($Million)
Table 37.Europe Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 38.Europe Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 39.Germany Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 40.Germany Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 41.France Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 42.France Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 43.UK Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 44.UK Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 45.Italy Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 46.Italy Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 47.Spain Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 48.Spain Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 49.Rest of Europe Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 50.Rest of Europe Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 51.Asia-Pacific Home Infusion Therapy Market, By Country, 2012-2022 ($Million)
Table 52.Asia-Pacific Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 53.Asia-Pacific Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 54.Japan Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 55.Japan Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 56.China Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 57.China Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 58.Australia Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 59.Australia Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 60.India Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 61.India Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 62.South Korea Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 63.South Korea Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 64.Rest of Asia-Pacific Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 65.Rest of Asia-Pacific Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 66.Rest of the World Home Infusion Therapy Market, By Country, 2012-2022 ($Million)
Table 67.Rest of the World Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 68.Rest of the World Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 69.Brazil Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 70.Brazil Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 71.Turkey Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 72.Turkey Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 73.Saudi Arabia Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 74.Saudi Arabia Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 75.South Africa Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 76.South Africa Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 77.United Arab Emirates Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 78.United Arab Emirates Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 79.Others Home Infusion Therapy Market, By Product, 2012-2022 ($Million)
Table 80.Others Home Infusion Therapy Market, By Application, 2012-2022 ($Million)
Table 81.B. Braun Melsungen AG: Key Strategic Developments, 2017-2017
Table 82.Baxter Inc.: Key Strategic Developments, 2017-2017
Table 83.Caesarea Medical Electronics: Key Strategic Developments, 2017-2017
Table 84.CareFusion Corporation: Key Strategic Developments, 2017-2017
Table 85.Fresenius Kabi: Key Strategic Developments, 2017-2017
Table 86.ICU Medical Inc.: Key Strategic Developments, 2017-2017
Table 87.JMS Co. Ltd.: Key Strategic Developments, 2017-2017
Table 88.Smiths Medical: Key Strategic Developments, 2017-2017
Table 89.Terumo Corporation: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Global Home Infusion Therapy Market Share, By Product, 2017 & 2025
Figure 2.Global Home Infusion Therapy Market, By Application, 2017, ($Million)
Figure 3.Global Home Infusion Therapy Market, By Region, 2017, ($Million)
Figure 4.B. Braun Melsungen AG: Net Revenues, 2017-2017 ($Million)
Figure 5.B. Braun Melsungen AG: Net Revenue Share, By Segment, 2017
Figure 6.B. Braun Melsungen AG: Net Revenue Share, By Geography, 2017
Figure 7.Baxter Inc.: Net Revenues, 2017-2017 ($Million)
Figure 8.Baxter Inc.: Net Revenue Share, By Segment, 2017
Figure 9.Baxter Inc.: Net Revenue Share, By Geography, 2017
Figure 10.Caesarea Medical Electronics: Net Revenues, 2017-2017 ($Million)
Figure 11.Caesarea Medical Electronics: Net Revenue Share, By Segment, 2017
Figure 12.Caesarea Medical Electronics: Net Revenue Share, By Geography, 2017
Figure 13.CareFusion Corporation: Net Revenues, 2017-2017 ($Million)
Figure 14.CareFusion Corporation: Net Revenue Share, By Segment, 2017
Figure 15.CareFusion Corporation: Net Revenue Share, By Geography, 2017
Figure 16.Terumo Corporation: Net Revenues, 2017-2017 ($Million)
Figure 17.Terumo Corporation: Net Revenue Share, By Segment, 2017
Figure 18.Terumo Corporation: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|